Saroglitazar API is a dual PPAR-α/γ agonist used in the management of diabetic dyslipidemia and hypertriglyceridemia in patients with type 2 diabetes mellitus. It works by improving lipid metabolism and insulin sensitivity. Saroglitazar API is manufactured under GMP-compliant conditions and is suitable for oral tablet formulations.

Saroglitazar API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.